跳至主要内容
临床试验/CTRI/2022/05/042352
CTRI/2022/05/042352尚未招募2 期

Role of Kashmarya-Kshudrasaha Ksheerapaka and AshwagandhaKsheerapaka in the management of Vatika Artavadushti â?? A RandomizedComparative Clinical Trial.

ATIONAL INSTITUTE OF AYURVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients complaining of Vatika Artavadushti with any two of the following manifestations:
  • 1. Artava vaivarnya (Discolored Menstrual Blood) - Aruna varna (Red/Reddish Brown/Tawny) or Shyava varna (Dark Brown) or Krishna varna (Black).
  • 2. Alpa Artava (Hypomenorrhoea)
  • 3. Vicchinna Artava (Interrupted flow)
  • 4. Saruja Artava (Painful Menses)
  • 5. Artava Chiraat Nishichyate (Oligomenorrhoea).
  • Female patients of age group 12 â?? 50 years.
  • Hb% >= 8 gm/dl.

排除标准

  • 1. Pregnant woman
  • 2. Patient having any systemic disease.
  • 3. Post menopausal woman.
  • 4. Patient having any type of malignancy.
  • 5. Patient having Sexually Transmitted Diseases.
  • 6. Patient using oral contraceptive pills and Intra Uterine Contraceptive
  • 7. Patient with thyroid hormone abnormalities.
  • 8. Patient having any other Uterine or Pelvic pathology like â?? Polyp,
  • Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic
  • Inflammatory Diseases, etc.
  • 9. Patients vaccinated for COVID-19 within three months.

研究者

相似试验